Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

More articles from Special Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

  • You have access
    International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
    Nick Z. Lu, Suzanne E. Wardell, Kerry L. Burnstein, Donald Defranco, Peter J. Fuller, Vincent Giguere, Richard B. Hochberg, Lorraine McKay, Jack-Michel Renoir, Nancy L. Weigel, Elizabeth M. Wilson, Donald P. McDonnell and John A. Cidlowski
    Pharmacological Reviews December 2006, 58 (4) 782-797; DOI: https://doi.org/10.1124/pr.58.4.9
  • You have access
    International Union of Pharmacology. LXVI. Orphan Nuclear Receptors
    Gérard Benoit, Austin Cooney, Vincent Giguere, Holly Ingraham, Mitch Lazar, George Muscat, Thomas Perlmann, Jean-Paul Renaud, John Schwabe, Frances Sladek, Ming-Jer Tsai and Vincent Laudet
    Pharmacological Reviews December 2006, 58 (4) 798-836; DOI: https://doi.org/10.1124/pr.58.4.10
  • You have access
    Foreword
    Vincent Laudet and Michael Spedding
    Pharmacological Reviews December 2006, 58 (4) 684; DOI: https://doi.org/10.1124/pr.58.4.1
  • You have access
    Overview of Nomenclature of Nuclear Receptors
    Pierre Germain, Bart Staels, Catherine Dacquet, Michael Spedding and Vincent Laudet
    Pharmacological Reviews December 2006, 58 (4) 685-704; DOI: https://doi.org/10.1124/pr.58.4.2
  • You have access
    International Union of Pharmacology. LIX. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Thyroid Hormone Receptors
    Frédéric Flamant, John D. Baxter, Douglas Forrest, Samuel Refetoff, Herbert Samuels, Tom S. Scanlan, Bjorn Vennström and Jacques Samarut
    Pharmacological Reviews December 2006, 58 (4) 705-711; DOI: https://doi.org/10.1124/pr.58.4.3
  • You have access
    International Union of Pharmacology. LX. Retinoic Acid Receptors
    Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf and Hinrich Gronemeyer
    Pharmacological Reviews December 2006, 58 (4) 712-725; DOI: https://doi.org/10.1124/pr.58.4.4
  • You have access
    International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
    Liliane Michalik, Johan Auwerx, Joel P. Berger, V. Krishna Chatterjee, Christopher K. Glass, Frank J. Gonzalez, Paul A. Grimaldi, Takashi Kadowaki, Mitchell A. Lazar, Stephen O'Rahilly, Colin N. A. Palmer, Jorge Plutzky, Janardan K. Reddy, Bruce M. Spiegelman, Bart Staels and Walter Wahli
    Pharmacological Reviews December 2006, 58 (4) 726-741; DOI: https://doi.org/10.1124/pr.58.4.5
  • You have access
    International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
    David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
    Pharmacological Reviews December 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6
  • You have access
    International Union of Pharmacology. LXIII. Retinoid X Receptors
    Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf and Hinrich Gronemeyer
    Pharmacological Reviews December 2006, 58 (4) 760-772; DOI: https://doi.org/10.1124/pr.58.4.7
  • You have access
    International Union of Pharmacology. LXIV. Estrogen Receptors
    Karin Dahlman-Wright, Vincent Cavailles, Suzanne A. Fuqua, V. Craig Jordan, John A. Katzenellenbogen, Kenneth S. Korach, Adriana Maggi, Masami Muramatsu, Malcolm G. Parker and Jan-Åke Gustafsson
    Pharmacological Reviews December 2006, 58 (4) 773-781; DOI: https://doi.org/10.1124/pr.58.4.8
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics